Pharmagest Good Will from 2010 to 2026

PHF Stock  EUR 34.85  17.92  33.96%   
Pharmagest Interactive's Good Will is increasing over the last several years with slightly volatile swings. Good Will is predicted to flatten to about 67 M. Good Will is an intangible asset that arises when Pharmagest Interactive SA acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors. View All Fundamentals
 
Good Will  
First Reported
2010-12-31
Previous Quarter
103.7 M
Current Value
67 M
Quarterly Volatility
26.6 M
 
Credit Downgrade
 
Yuan Drop
 
Covid
 
Interest Hikes
Check Pharmagest Interactive financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Pharmagest Interactive's main balance sheet or income statement drivers, such as Tax Provision of 8.8 M, Net Interest Income of 2.7 M or Discontinued Operations of 108.6 K, as well as many indicators such as . Pharmagest financial statements analysis is a perfect complement when working with Pharmagest Interactive Valuation or Volatility modules.
  
This module can also supplement various Pharmagest Interactive Technical models . Check out the analysis of Pharmagest Interactive Correlation against competitors.
The Good Will trend for Pharmagest Interactive SA offers valuable insights into the company's financial trajectory and strategic direction. By examining multi-year patterns, investors can identify whether Pharmagest Interactive is strengthening or weakening its position, and how this metric correlates with broader market conditions and industry benchmarks.

Latest Pharmagest Interactive's Good Will Growth Pattern

Below is the plot of the Good Will of Pharmagest Interactive SA over the last few years. It is an intangible asset that arises when a company acquires another business for more than the fair market value of its net identifiable assets, representing the value of the brand, customer base, and other intangible factors. Pharmagest Interactive's Good Will historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Pharmagest Interactive's overall financial position and show how it may be relating to other accounts over time.
Good Will10 Years Trend
Slightly volatile
   Good Will   
       Timeline  

Pharmagest Good Will Regression Statistics

Arithmetic Mean54,776,415
Geometric Mean49,081,335
Coefficient Of Variation48.52
Mean Deviation23,525,311
Median46,005,000
Standard Deviation26,575,089
Sample Variance706.2T
Range73.2M
R-Value0.89
Mean Square Error155T
R-Squared0.79
Slope4,690,268
Total Sum of Squares11299.8T

Pharmagest Good Will History

202667 M
2025103.7 M
202390.2 M
202283.1 M
202183.7 M
202065.6 M
201949.8 M

About Pharmagest Interactive Financial Statements

Pharmagest Interactive stakeholders use historical fundamental indicators, such as Pharmagest Interactive's Good Will, to determine how well the company is positioned to perform in the future. Although Pharmagest Interactive investors may analyze each financial statement separately, they are all interrelated. For example, changes in Pharmagest Interactive's assets and liabilities are reflected in the revenues and expenses on Pharmagest Interactive's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Pharmagest Interactive SA. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Good Will103.7 M67 M

Currently Active Assets on Macroaxis

Other Information on Investing in Pharmagest Stock

Pharmagest Interactive financial ratios help investors to determine whether Pharmagest Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Pharmagest with respect to the benefits of owning Pharmagest Interactive security.